Nepean Lung Cancer Biobank

Certification Status: Checklist Required

Registration Status: Completed

Objective:

A global open access prospective lung cancer biobank for future unspecified medical research. In addition, lung cancer clinical trial sub-studies and project specific collections can be facilitated by the NCRB through an application process.

Registered Biobank Name	Nepean Lung Cancer Biobank (NLCB)
Biobank Leader	Lisa Kay
Principal Investigator	Professor Lucy Morgan
Address	Nepean Hospital, Nepean Cancer Care Centre, Corner of Somerset Street and Great Western Highway Penrith, NSW, Australia
Website
Email for biobank inquiries	NBMLHD-Biobank@health.nsw.gov.au
User Type Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper	Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.

Biospecimen Collected: